Guardant Health (GH) Common Equity (2017 - 2026)

Guardant Health has disclosed Common Equity across 10 years of filings, most recently posting -$181.1 million for Q1 2026.

• Common Equity for Q1 2026 came in at -$181.1 million, up 27.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$181.1 million (up 27.8% YoY), and the FY2025 annual result was -$99.3 million, up 28.89% from the prior year.
• Common Equity came in at -$181.1 million for Q1 2026 at Guardant Health, down from -$99.3 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $533.0 million in Q1 2022 to a low of -$354.5 million in Q3 2025.
• The 5-year median for Common Equity is -$1.6 million (2024), against an average of $22.9 million.
• Across the five-year window, Common Equity jumped 253.27% in 2024 and slumped 18838.31% in 2025, its largest moves.
• Guardant Health's Common Equity stood at $60.2 million in 2022, then surged by 163.68% to $158.7 million in 2023, then plunged by 188.0% to -$139.6 million in 2024, then advanced by 28.89% to -$99.3 million in 2025, then sank by 82.34% to -$181.1 million in 2026.
• The last three Common Equity figures came in at -$181.1 million (Q1 2026), -$99.3 million (Q4 2025), and -$354.5 million (Q3 2025), per Business Quant data.